文献速递前列腺癌

根治性放疗后经会阴模板穿刺活检确定的前列腺内癌症复发模式:对局灶消融挽救治疗的启示

Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
PubMed 文献 · J Urol · 2020-06-30

研究纳入145例外照射放疗或近距离放疗后生化复发、接受经会阴模板前列腺定位活检的患者,评估复发模式及局灶消融挽救治疗适用性。结果显示75.9%(110例)适合某种形式的局灶挽救治疗,其中40.7%适合象限消融、14.5%适合半腺消融、14.5%适合双侧局灶消融、6.2%适合索引病灶消融。

要点

  • 放疗后生化复发患者中约四分之三基于模板穿刺活检适合局灶消融挽救治疗。
  • 适用性标准包括单灶或单侧病变,或双侧/多灶但仅一个优势索引病灶且次要病灶为Gleason 3+3=6、癌核心受累≤3 mm。
  • 象限消融是最常见的适用形式(40.7%)。

核心结论

  • 基于经会阴模板前列腺定位活检,约四分之三的局部放射性复发前列腺癌患者可能适合局灶消融治疗。

主要发现

  • 患者平均年龄70.7岁(SD 5.8)。
  • 活检时前列腺特异性抗原中位数4.5 ng/ml(IQR 2.5-7.7)。
  • 75.9%(110例)适合某种形式局灶挽救治疗。
  • 40.7%(59例)适合象限消融,14.5%(21例)适合半腺消融,14.5%(21例)适合双侧局灶消融,6.2%(9例)适合索引病灶消融。

关键数值与推荐

  • 局灶消融适用性要求癌症为单灶或单侧,或双侧/多灶但仅一个优势索引病灶且次要病灶Gleason评分3+3=6、癌核心受累不超过3 mm。

临床怎么用

  • 对于放疗后生化复发且怀疑局部复发的患者,经会阴模板前列腺定位活检可识别适合局灶消融挽救治疗的候选者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Men in whom external beam radiotherapy fails are usually placed on delayed hormone therapy. Some of these men have localized recurrence that might be suitable for further local therapy. We describe patterns of recurrence and suitability for focal ablative therapy in those undergoing transperineal template prostate mapping biopsies. MATERIALS AND METHODS: The study included 145 consecutive patients (December 2007 to May 2014) referred with suspicion of recurrence due to rising prostate specific antigen after external beam radiotherapy or brachytherapy who underwent transperineal template prostate mapping biopsies. Suitability for focal ablative therapy required the cancer to be unifocal or unilateral, or bilateral/multifocal with 1 dominant index lesion and secondary lesions with Gleason score 3+3=6 with no more than 3 mm cancer core involvement. RESULTS: Mean patient age was 70.7 (SD 5.8) years. Median prostate specific antigen at time of transperineal template prostate mapping biopsy was 4.5 ng/ml (IQR 2.5-7.7). Overall 75.9% (110) were suitable for a form of focal salvage treatment, 40.7% (59) were suitable for quadrant ablation, 14.5% (21) hemiablation, 14.5% (21) bilateral focal ablation and 6.2% (9) for index lesion ablation. CONCLUSIONS: Three-quarters of patients who have localized radiorecurrent prostate cancer may be suitable for focal ablative therapy to the prostate based on transperineal template prostate mapping biopsies.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Kanthabalan A, Arya M, Freeman A, et al. Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy. J Urol. 2020. PMID: 32602770. doi:10.1097/JU.0000000000001201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。